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Two recent papers in Nature describe a remarkable new technique for reprogramming somatic cells back to
the embryonic state. Obokata et al. (2014a, 2014b) show that applying stressful stimuli can convert mature
cells into progenitors capable of generating all three embryonic germ layer lineages, as well as placental
tissue.Until 1996, it was widely considered that
the classic cloning experiments of Gurdon
in amphibians could not be accomplished
in mammals. The birth of Dolly the Sheep
(Campbell et al., 1996) abruptly changed
these views. After Dolly, it was clear that
adult mammalian cell nuclei could indeed
undergo the dramatic epigenetic reprog-
ramming required to reset their develop-
mental clock back to the embryonic state,
but many imagined that this complex pro-
cess required the action of hundreds of
unknown regulatory molecules present
in the egg (Surani, 2012). Then Shinya
Yamanaka showed that cellular reprog-
ramming could be achieved by transduc-
tion of a few master regulatory transcrip-
tion factors (Takahashi and Yamanaka,
2006).
Now, two new studies by Obokata et al.
(2014a, 2014b) reveal an even simpler and
more efficient route to somatic cell re-
programming. The authors demonstrate
that transient immersion of cells from a
range of mature tissues in a mildly acidic
solution, or exposure to certain other
forms of stress, converts them to a plurip-
otent cell type called a STAP cell. By
tracking the generation of STAP cells
from CD45+ hematopoietic cells by using
a Pou5F1 reporter cell line, the authorsshowed that STAP cells arise through re-
programming rather than the selection of
a rare cell type present in the starting pop-
ulation to begin with. Although STAP cells
are unable to undergo significant replica-
tion, they display gene-expression pat-
terns similar to embryonic cells and can
participate in chimera formation when
injected into mice. Remarkably, STAP
cells even contributed to the germline of
chimeric mice. STAP cells can be further
converted in vitro into cells closely resem-
bling embryonic stem cells. Interestingly,
this conversion did not occur under con-
ventional culture conditions for mouse
embryonic stem cells, but required culti-
vation in the presence of ACTH, shown
previously to be an alternative factor
for stem cell maintenance (Ogawa et al.,
2004). When grown under conditions
that support trophectoderm growth,
STAP cells gave rise to a new cell type,
similar to previously described tropho-
blast stem cells, but having the unique
property of being convertible to an embry-
onic stem cell-like state (Obokata et al.,
2014a).
The main claims of these two studies
are supported by an impressive array of
rigorous experimentation, carried out by
some of the world’s leading experts inpluripotency, but they have nevertheless
been received with a healthy degree
of skepticism. Because the experimental
manipulations involved appear to be
relatively simple, and many labora-
tories are actively geared up to study
cellular reprogramming, we will know
soon enough whether these striking
results are reproducible in the mouse
and whether they can be extended to
adult cells and to cells from other spe-
cies, including humans. Concerns over
possible image duplication have cast
something of a shadow over the new
studies, but at present the validity of their
conclusions is not in doubt.
Assuming that these findings are
robust, they raise some wide-ranging
questions about the stability of the differ-
entiated state (Bonfanti et al., 2012). Re-
programming a cell by propagating it in
the unnatural environment of cell culture
and subjecting it to a blast of powerful
exogenous transcriptional regulators is
one thing, but a brief exposure to mildly
acidic conditions is another. Cells in the
body often encounter stresses similar to
those used in STAP induction, but they
nevertheless remained locked into spe-
cific committed or differentiated states
by powerful epigenetic restraints on14, March 6, 2014 ª2014 Elsevier Inc. 273
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straints are maintained consistently
through thousands of cell divisions in
renewing cell populations, such as those
in the gut or bone marrow, and during
regeneration and repair in the face of
harsh environmental insults in other tis-
sues. The logical outcome of STAP cell
generation in vivo would be formation of
a teratoma. But naturally occurring tera-
tomas are extraordinarily rare, and their
origins can be traced back to the germline
(a lineage very close to pluripotent cells
embryologically) rather than to somatic
cells. There is, of course, precedent for
stress-induced changes in the differenti-
ated state of somatic cells, for example,
intestinal metaplasia in the esophagus,
which is thought to be a consequence
of acid reflux. Obokata et al. (2014b)
report some intriguing preliminary data
indicating that Pou5F1 but not Nanog
expression is activated in an experimental
model of reflux esophagitis, suggesting
that the tissue environment provides un-
known barriers to STAP reprogramming.
The findings of Obokata et al. (2014b)
will spur renewed efforts to understand
the mechanisms that ensure the stability
of the differentiated state (Blau, 1992) of
cells in the body.
The new results will also undoubtedly
spark additional interest around a whole
raft of incompletely understood phenom-
ena relating to the possible existence of274 Cell Stem Cell 14, March 6, 2014 ª2014cells with pluripotent phenotypes in adult
tissues. For example, several groups
havedescribed subsets of stress-resistant
mesenchymal stem cells that display
features of pluripotency (Wakao et al.,
2014). Unravelling the mechanism of
STAP reprogramming, and understanding
how this process relates to reprogram-
ming by somatic cell nuclear transfer or
by defined factors, will also be a fertile
ground for future investigation. In addition,
there are some intriguing corollaries of
the concept that, in developmental terms,
STAP cells might not correspond to any
cell state in normal embryogenesis, but
might instead represent a novel epigenetic
condition that provides a complete blank
slate for specification and differentiation.
There has been considerable interest
in the concept and application of direct
cellular reprogramming, or converting one
specialized cell type to another without
going through a pluripotent intermedi-
ate (Chambers and Studer, 2011). Will
elements of STAP reprogramming proto-
cols offer a more efficient and simple route
to direct interconversion of tissue cell
types?
Finally if the STAP technique works
with human cells, how will it impact on
the development of cell lines for research
and therapy? The STAP methodology ap-
pears to yield pluripotent stem cell lines
rapidly and with high efficiency. However,
it will only be after extensive preclinicalElsevier Inc.studies and clinical trials that we will
have some appreciation of the place that
embryonic stem cells, induced pluripotent
stem cells, and STAP cells will play in dis-
ease modeling and patient treatment. In
the end, regardless of their provenance,
pluripotent stem cells have a common
set of hurdles to overcome prior to their
application in regenerative medicine.REFERENCES
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